B6V-19045-93154
1 vaccination
2 coded responses
5 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 064 / CT
- Registered
- 2021-05-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-05
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-06
Registered in v-safe
-
2021-05-06
Survey response — days 1–6 daily, dose 1MedDRA: Postpartum state — Feeling: Fair · Fever · Fatigue or tirednessFree text: 72 hours postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Fatigue or tirednessFree text: I am 5 days postpartum if that makes any differenceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-09
- 2021-05-11
- 2021-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-05 | Janssen/Johnson & Johnson |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): 72 hours postpartum
Systemic reaction (other): I am 5 days postpartum if that makes any difference
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Postpartum state | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release